Home › Breast Cancer › NCT07044583
SAVE Trial: SAfe Opioid Use Video Education
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Female patients 18 years of age or older * Patients undergoing abdominally based autologous free flap breast reconstruction after mastectomy for breast cancer or cancer prophylaxis Exclusion Criteria: * Patients undergoing reoperations such as autologous breast reconstruction as a revision procedure following failed implant-based reconstruction * Patients undergoing multiple procedures such as mastectomy and immediate reconstruction * Patients with documented chronic opioid use prior to procedure, chronic pain condition
About the study
The study will assess the efficacy of a standardized postoperative patient-centered intervention designed to educate patients on the opioid epidemic, the judicious use of opioids, and the proper disposal of opioids. This trial is a single-institution, randomized controlled trial comparing total post-discharge opioid use in breast reconstruction patients who view an educational video on proper opioid use to patients who do not receive intentional education (the current standard of care).
This will be the first project to inform opioid prescribing guidelines for breast reconstruction patients based on actual opioid use data and will describe a patient-centered intervention that is easily incorporated into current postoperative workflows. Broadly, the results of the study aim to set the foundation to incorporate cost-effective educational interventions across multiple surgical specialties that require postoperative opioid prescription.
What is being tested
- Opioid Educational Video (behavioral)
Sponsor: University of Utah · Participants: 68 · Started: Oct 27, 2025
Contact the study team
- Jay Agarwal, MD · Phone: 801-585-2318
- Ethan Lester · Phone: 203-450-2599
Official record on ClinicalTrials.gov — NCT07044583
Locations in the U.S.
| Utah | University of Utah Huntsman Cancer Institute, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.